REVELATION BIOSCIENCES, INC. Depreciation
REVELATION BIOSCIENCES, INC. (REVB) reported Depreciation of $8.31 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-06
- REVELATION BIOSCIENCES, INC. depreciation for the quarter ending 2026-06-30 was $8.31K, a 15.14% increase year-over-year.
- REVELATION BIOSCIENCES, INC. depreciation for the quarter ending 2026-03-31 was $7.20K, a 0.25% decline year-over-year.
- REVELATION BIOSCIENCES, INC. depreciation for the quarter ending 2025-12-31 was $5.85K, a 18.96% decline year-over-year.
- REVELATION BIOSCIENCES, INC. depreciation for the quarter ending 2025-09-30 was $6.76K, a 6.30% decline year-over-year.
- REVELATION BIOSCIENCES, INC. depreciation for fiscal 2025 was $27.06K, a 3.10% decline from fiscal 2024.
- REVELATION BIOSCIENCES, INC. depreciation for fiscal 2024 was $27.92K, a 11.47% increase from fiscal 2023.
- REVELATION BIOSCIENCES, INC. depreciation for fiscal 2023 was $25.05K, a 0.00% increase from fiscal 2022.
- REVELATION BIOSCIENCES, INC. depreciation for fiscal 2022 was $25.05K, a 49.26% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.31K 10-Q · filed 2026-08-06 | $15.52K 10-Q · filed 2026-08-06 | $21.37K derived: sum of 3 quarters · filed 2026-08-06 | $28.13K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $7.20K 10-Q · filed 2026-05-07 | $13.05K derived: sum of 2 quarters · filed 2026-05-07 | $19.82K derived: sum of 3 quarters · filed 2026-05-07 | $27.04K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $5.85K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $12.62K derived: sum of 2 quarters · filed 2026-02-26 | $19.84K derived: sum of 3 quarters · filed 2026-08-06 | $27.06K 10-K · filed 2026-02-26 |
| 2025-09-30 | $6.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $13.98K derived: sum of 2 quarters · filed 2026-08-06 | $21.21K 10-Q · filed 2025-11-06 | $28.43K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $7.22K 10-Q · filed 2026-08-06 | $14.44K 10-Q · filed 2026-08-06 | $21.66K derived: sum of 3 quarters · filed 2026-08-06 | $28.88K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $7.22K 10-Q · filed 2026-05-07 | $14.44K derived: sum of 2 quarters · filed 2026-05-07 | $21.66K derived: sum of 3 quarters · filed 2026-05-07 | $28.88K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $7.22K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $14.44K derived: sum of 2 quarters · filed 2026-02-26 | $21.66K derived: sum of 3 quarters · filed 2026-02-26 | $27.92K 10-K · filed 2026-02-26 |
| 2024-09-30 | $7.22K 10-Q · filed 2024-11-08 | $14.44K derived: sum of 2 quarters · filed 2024-11-08 | $20.70K 10-Q · filed 2025-11-06 | $26.96K derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-06-30 | $7.22K 10-Q/A · filed 2024-09-23 | $13.48K 10-Q · filed 2025-08-08 | $19.74K derived: sum of 3 quarters · filed 2025-05-08 | $26.01K derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-03-31 | $6.26K 10-Q · filed 2025-05-08 | $12.52K derived: sum of 2 quarters · filed 2025-05-08 | $18.79K derived: sum of 3 quarters · filed 2025-05-08 | $25.05K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $6.26K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $12.52K derived: sum of 2 quarters · filed 2025-03-06 | $18.79K derived: sum of 3 quarters · filed 2025-03-06 | $25.05K 10-K · filed 2025-03-06 |
| 2023-09-30 | $6.26K 10-Q · filed 2024-11-08 | $12.52K derived: sum of 2 quarters · filed 2024-11-08 | $18.79K 10-Q · filed 2024-11-08 | $25.05K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $6.26K 10-Q/A · filed 2024-09-23 | $12.53K 10-Q/A · filed 2024-09-23 | $18.79K derived: sum of 3 quarters · filed 2024-09-23 | $25.05K derived: sum of 4 quarters · filed 2024-09-23 |
| 2023-03-31 | $6.26K 10-Q/A · filed 2024-09-23 | $12.53K derived: sum of 2 quarters · filed 2024-09-23 | $18.79K derived: sum of 3 quarters · filed 2024-09-23 | $25.05K derived: sum of 4 quarters · filed 2024-09-23 |
| 2022-12-31 | $6.26K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-09-23 | $12.52K derived: sum of 2 quarters · filed 2024-09-23 | $18.79K derived: sum of 3 quarters · filed 2024-09-23 | $25.05K 10-K/A · filed 2024-09-23 |
| 2022-09-30 | $6.26K 10-Q · filed 2023-11-09 | $12.52K derived: sum of 2 quarters · filed 2023-11-09 | $18.79K 10-Q · filed 2023-11-09 | $25.05K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $6.26K 10-Q · filed 2023-08-11 | $12.52K 10-Q · filed 2023-08-11 | $18.79K derived: sum of 3 quarters · filed 2023-08-11 | $24.86K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $6.26K 10-Q · filed 2023-05-22 | $12.52K derived: sum of 2 quarters · filed 2023-05-22 | $18.59K derived: sum of 3 quarters · filed 2023-05-22 | $19.24K derived: sum of 4 quarters · filed 2023-05-22 |
| 2021-12-31 | $6.26K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $12.33K derived: sum of 2 quarters · filed 2023-03-30 | $12.97K derived: sum of 3 quarters · filed 2023-03-30 | $16.78K 10-K · filed 2023-03-30 |
| 2021-09-30 | $6.07K 10-Q · filed 2022-11-10 | $6.71K derived: sum of 2 quarters · filed 2022-11-10 | $10.52K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $642.00 10-Q · filed 2022-08-15 | $4.45K 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $642.00 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |